Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...
SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...
Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...
MS advocate and real estate investor Tamiko Ryan talks about the frustrations of getting proper treatments and shares strategies to help you get the support you need to manage MS and thrive. Multiple ...
WALTHAM, Mass., May 29, 2024 /PRNewswire/ -- The iConquerMS™ People-Powered Research Network (PPRN) (www.iConquerMS.org), a research initiative of the Accelerated Cure Project (ACP), is partnering ...
A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...
Hosted on MSN
How to Manage Speech Problems Linked to MS
Multiple sclerosis (MS) is a chronic, often progressive disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. While the most common symptoms include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback